U.S. markets closed
  • S&P 500

    3,435.56
    -7.56 (-0.22%)
     
  • Dow 30

    28,210.82
    -97.97 (-0.35%)
     
  • Nasdaq

    11,484.69
    -31.80 (-0.28%)
     
  • Russell 2000

    1,603.78
    -13.93 (-0.86%)
     
  • Crude Oil

    39.92
    -0.11 (-0.27%)
     
  • Gold

    1,927.70
    -1.80 (-0.09%)
     
  • Silver

    25.15
    -0.09 (-0.36%)
     
  • EUR/USD

    1.1861
    -0.0006 (-0.05%)
     
  • 10-Yr Bond

    0.8160
    +0.0190 (+2.38%)
     
  • GBP/USD

    1.3136
    -0.0008 (-0.06%)
     
  • USD/JPY

    104.6300
    +0.0700 (+0.07%)
     
  • BTC-USD

    12,839.64
    +1,782.63 (+16.12%)
     
  • CMC Crypto 200

    258.26
    +13.37 (+5.46%)
     
  • FTSE 100

    5,776.50
    -112.72 (-1.91%)
     
  • Nikkei 225

    23,639.46
    +72.42 (+0.31%)
     

SHAREHOLDER ALERT: STAA AEP ODT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

·3 mins read

NEW YORK, NY / ACCESSWIRE / September 20, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Staar Surgical Company (NASDAQ:STAA)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/staar-surgical-company-loss-submission-form?prid=9422&wire=1
Lead Plaintiff Deadline: October 19, 2020
Class Period: February 26, 2020 - August 10, 2020

Allegations against STAA include that: the Company was overstating and/or mischaracterizing: (1) its sales and growth in China; (2) its marketing spend; (3) its research and development expenses; and that as a result of the foregoing, (4) Defendants' public statements were materially false and misleading at all relevant times.

American Electric Power Company, Inc. (NYSE:AEP)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/american-electric-power-company-inc-loss-submission-form?prid=9422&wire=1
Lead Plaintiff Deadline: October 19, 2020
Class Period: November 2, 2016 - July 24, 2020

Allegations against AEP include that: (1) the Company covertly participated in the "the largest public corruption case in Ohio history"; (2) the Company secretly funneled substantial funds to Ohio political organizations and politicians to bribe politicians to pass Ohio House Bill 6 ("HB6"), which benefited the Company and its coal-fired generation assets; (3) the Company partially funded a massive, misleading advertising campaign in support of HB6 and in opposition to a ballot initiative to repeal HB6 by passing substantial sums through a web of dark money entities and front companies in order to conceal the Company's involvement; (4) the Company aided in subverting a citizens' ballot initiative to repeal HB6; (5) as a result of the foregoing, defendants' statements regarding the Company's regulatory and legislative efforts were materially false and misleading; 6) as a result of the foregoing, the Company would face increased scrutiny; (7) the Company was subject to undisclosed risk of reputational, legal, and financial harm; (8) the bribery scheme would jeopardize the benefits the Company sought brought by HB6; (9) as opposed to the its repeated public statements regarding a move to clean energy, the Company sought a dirty energy bailout; (10) as opposed to the Company's repeated public statements regarding protection of its customers' interests, the Company sought an extra and state-mandated surcharge on its customers' bills; and (11) as a result of the foregoing, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Odonate Therapeutics, Inc. (NASDAQ:ODT)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/odonate-therapeutics-inc-loss-submission-form?prid=9422&wire=1
Lead Plaintiff Deadline: November 16, 2020
Class Period: December 7, 2017 - April 21, 2020

Allegations against ODT include that: (i) the Company's orally administered chemotherapy agent, tesetaxel, was not as safe or well-tolerated as the Company had led investors to believe; (ii) consequently, tesetaxel's commercial viability as a cancer treatment was overstated; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong



View source version on accesswire.com:
https://www.accesswire.com/606907/SHAREHOLDER-ALERT-STAA-AEP-ODT-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines